Affiliation:
1. the BBSRC Centre for Genome Research, Edinburgh (UK) University (M.G.F.S., D.F., G.B., A.F.C., J.J.M.); Department of Pharmacology, University of Heidelberg (Germany) (J.P.); and Department of Pathology, University of Edinburgh (UK) (S.F.).
Abstract
Several recent studies have demonstrated that ablation of genes of the renin-angiotensin system can have wide-ranging and sometimes unexpected effects. Renin is directly involved in blood pressure regulation and is encoded by a single gene in most mammals. Wild mouse strains and some inbred laboratory strains have a duplicated renin gene (
Ren-2
), the physiological significance of which is unclear. Significant differences exist in the structure and expression of these renin genes, but as yet, no distinct biological function that distinguishes these genes has been defined. We have used gene targeting to discover the effects of inactivating the duplicated (
Ren-2
) gene in strain 129 mice, and we show that mice lacking the
Ren-2
gene are viable and healthy. There appear to be no histopathological differences in renin-expressing tissues between
Ren-2
–null mice and their controls. Studies of our
Ren-2
–null mice allow, for the first time, a direct evaluation of the ability of the
Ren-1
d
gene to regulate blood pressure in the absence of expression of the
Ren-2
enzyme. We observed no alteration to blood pressure in adult mice homozygous for the mutated
Ren-2
gene, even though the concentration of active renin is increased and of prorenin is decreased in plasma of these mice.
Ren-1
d
is therefore capable of regulating normal blood pressure and despite a different tissue expression profile, is functionally equivalent to
Ren-1
c
.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
76 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献